Capital Change Notice – Issue of ordinary shares
Capital Change Notice
AFT Pharmaceuticals Limited, Level 1, 129 Hurstmere Road, Takapuna, Auckland 0622, New Zealand
Incorporated in New Zealand ARBN:
ARBN 609 017 969 investor.relations@aftpharm.com
14 April 2021
Issue of ordinary shares
This notice is given under NZX Listing Rule 3.13.1 and relates to the issue of ordinary shares in
AFT Pharmaceuticals Limited under the AFT Pharmaceuticals Limited Long Term Incentive Plan.
Section 1: Issuer information
Name of issuer AFT Pharmaceuticals Limited
NZX ticker code AFT
Class of financial product Ordinary shares
ISIN (If unknown, check on NZX website) NZAFTE0001S4
Currency NZD
Section 2: Capital change details
Number issued 60,000
Nominal value (if any) Not applicable
Issue price per security $2.80
Nature of the payment Not applicable
Amount paid up (if not in full) In full
Percentage of total class of Financial Products issued
(calculated on the number of Financial Products of the
Class, excluding any Treasury Stock, in existence)
0.057%
For an issue of Convertible Financial Products or
Options, the principal terms of Conversion
Not applicable
Reason for issue and specific authority for issue 60,000 shares were issued to an
employee exercising options under the
AFT Pharmaceuticals Limited Long
Term Incentive Plan
Total number of Financial Products of the Class after
the issue (excluding Treasury Stock) and the total
number of Financial Products of the Class held as
Treasury Stock after the issue.
104,643,875
Specific authority for the issue, including a reference
to the rule pursuant to which the issue is made
Directors’ resolution, Listing Rule 4.6
Terms or details of the issue (for example: restrictions,
escrow arrangements)
The ordinary shares issued rank pari
passu with the existing ordinary shares
Date of issue 13 April 2021
AFT Pharmaceuticals Limited, Level 1, 129 Hurstmere Road, Takapuna, Auckland 0622, New Zealand
Incorporated in New Zealand ARBN:
ARBN 609 017 969 investor.relations@aftpharm.com
Section 3: Authority for this announcement and contact person
Name of person
authorised to make this
announcement
Malcolm Tubby
Contact person for this announcement Malcolm Tubby
Contact phone number +64 9 488 0232
Contact email address malcolm@aftpharm.com
Date of release through MAP
14 April 2021
Data sourced from publicly available filings. Our datasets may not be complete. Automated analysis can produce errors. If you believe any data on this page is incorrect, please contact us at hello@nzxplorer.co.nz. For informational purposes only. Not investment advice.
Other issuers discussed similar conditions around this time
Matched by meaning across NZX announcement text, not keywords — based on our semantic index of announcement bodies.
- ATM — The a2 Milk Company Limited: Capital Change Notice2021-03-02
“Capital Change Notice Updated as at 17 October 2019 Notice of issue of ordinary shares This notice is given under the NZX Listing Rules 3.13.1 and 3.15.2 and relates to the exercise of options issued on 17 August 2015 (and expiring on 12 May 2021) to subscribe for fully…”
- ATM — The a2 Milk Company Limited: Capital Change Notice2021-03-10
“Capital Change Notice Updated as at 17 October 2019 Notice of issue of rights This notice is given under the NZX Listing Rule 3.13.1 and relates to the issue of rights under ATM’s Long Term Incentive Plan (LTI Plan). Section 1: Issuer information Name of issuer T…”
- ATM — The a2 Milk Company Limited: Capital Change Notice2021-04-28
“Capital Change Notice Updated as at 17 October 2019 Notice of issue of Ordinary Shares and Matching Rights under The a2 Milk Company Limited’s (ATM) Share Match Plan This notice is given under the NZX Listing Rule 3.13.1 and relates to the issue of fully paid Ordi…”